The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManchester&lon. Regulatory News (MNL)

Share Price Information for Manchester&lon. (MNL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 728.00
Bid: 722.00
Ask: 730.00
Change: 2.00 (0.28%)
Spread: 8.00 (1.108%)
Open: 708.00
High: 730.00
Low: 708.00
Prev. Close: 726.00
MNL Live PriceLast checked at -
Manchester & London is an Investment Trust

To achieve capital appreciation together with a reasonable level of income by investing in a variety of sectors both in the UK and overseas as well as fixed income securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 Jun 2014 10:23

MANCHESTER & LONDON INVESTMENT TRUST PLC - Interim Management Statement

MANCHESTER & LONDON INVESTMENT TRUST PLC - Interim Management Statement

PR Newswire

London, June 19

Manchester and London Investment Trust plc 19 June 2014 Interim Management Statement (Unaudited) for the period ended 11 June 2014. This interim management statement relates to the period from 1 February 2014 to11 June 2014 and contains information that covers that period, unless otherwisestated. Subsequent to that period, the NAV per share decreased to 301.6p as at18 June 2014. Review of the Period * Over the period, the Group's net asset value and share price returns were 2.0 per cent and (4.1) per cent respectively. The Dow Jones U.K. Total Stock Market Index return was 4.4 per cent. * The interim dividend of 5.5p per share was declared on 27 March 2014 and paid on 30 April 2014. * Prior top 10 holdings Rio Tinto plc and Standard Chartered plc have been fully divested. Top 10 holdings BG Group plc, Diageo plc, Glencore plc, Syngenta AG and Unilever plc have been materially reduced. New top 10 holding AstraZeneca plc was purchased during the period. * Due to the reduction in long exposure, and therefore reduced hedging requirements, £30.1m of S&P 500 index shorts were closed in the period. All index short positions have now been exited, though the portfolio has £ 26.9m notional value in short dated, out of the money index puts as a partial hedge against a large downwards market move. Investment Objective The investment objective of the Company is to achieve capital appreciationtogether with a reasonable level of income. Financial Return (%) 2014 YTD 2013 2012 2011 2010 Share Price (13.9) 2.0 (25.9) 23.5 7.0 Net Asset Value (8.5) (0.6) (23.1) 15.3 15.2 Benchmark 3.8 20.1 (2.8) 11.5 15.0 Periods are financial years to 31 July. Financial Position As at 11 June 2014 As at 31 January 2014 Net Assets £68.7m £67.4m Share Price 258.1p 269.1p Net Asset Value 306.0p 299.9p Discount 15.7% 10.3% Gearing 90.9% 93.5% Share prices source: FactSet Research Systems Inc. Benchmark with thanks to: S&P Dow Jones Indices. Portfolio Analysis Top 15 Asset Values as at 11 June 2014. ("Asset Values" being positions reduced by the marked to market value ofcovered call options.) Stock Name % of Net Assets Sector PZ Cussons plc 23.8 Personal Goods Afren plc 7.0 Oil & Gas Producers AstraZeneca plc 6.9 Pharmaceuticals & Biotechnology Diageo plc 6.7 Beverages Jardine Matheson Holdings Ltd 6.4 General Industrial Glencore plc 5.7 Mining BG Group plc 5.3 Oil & Gas Producers Unilever plc 4.3 Food Producers bioMerieux SA 4.2 Medical Technology Syngenta AG 4.1 Chemicals KWS SAAT AG 3.0 Agrisciences Ishares FTSE 100 Ucits ETF 2.9 Equity Instruments(Inc) Pernod Ricard SA 2.3 Beverages Svenska Cellulosa AB 2.1 Household Utilities Echo Entertainment Group Ltd* 1.4 Travel & Leisure * now fully disposed of. Sector Analysis as at 11 June 2014 Sector % of Net Assets Personal Goods 23.8% Oil & Gas Producers 14.4% Cash and Other Assets/Liabilities 9.1% Beverages 9.0% Pharmaceuticals & Biotechnology 6.9% General Industrial 6.4% Mining 5.7% Equity Instruments 4.4% Food Producers 4.3% Medical Technology 4.2% Chemicals 4.1% Agrisciences 3.0% Household Utilities 2.1% Travel & Leisure 1.4% IT Hardware 1.2% Analysis of NAV Underperformance since 1 August 2013, relative to the benchmarkindex Divergence of S&P Index Hedge from Benchmark Index.* 3.7% Underperformance of PZ Cussons plc. 3.4% Underperformance of Standard Chartered plc.* 1.6% Underperformance of Medical, Technology & Agrisciences 1.5%Investments. Underperformance of Capital Goods Investments. 1.0% Underperformance of Diageo plc. 1.0% Underperformance of Burberry Group plc.* 0.9% Combined Other Factors. 0.8% Underperformance of Other Consumer Goods Investments. 0.8% Underperformance due to Net Long to Net Asset Leverage being 0.2%below 100% as the market rose. Underperformance of Oil & Gas Investments. (0.0)% Overperformance of Mining Investments. (0.7)% Overperformance of Event Driven Investments and Other Hedges. (1.9)% Total Underperformance. 12.3% * now fully disposed of. By order of the Board Michael Kurt Camp, for and on behalf of Manchester & London Investment Trustplc, Secretary. 19 June 2014. Registered office: Arthur House, Chorlton Street, Manchester, M1 3FH. Telephone: 0161 228 1709. This interim statement has been prepared solely to provide information to meetthe requirements of the UK Listing Authority's Disclosure and TransparencyRules. Please note that the up to date information on the Company, includingfactsheets and portfolio information can be found on the Company's website at: http://www.manchesterandlondon.co.uk/investorRelations.php Enquiries: Manchester & London Investment Trust plc.Michael Kurt CampTel: 0161 228 1709 Midas Investment Management Limited (Investment Manager to MNL).Mark SheppardTel: 0161 242 2895
Date   Source Headline
21st Jul 20211:24 pmPRNNet Asset Value(s)
14th Jul 20211:58 pmPRNNet Asset Value(s)
7th Jul 20212:07 pmPRNNet Asset Value(s)
30th Jun 20215:01 pmPRNDirector/PDMR Shareholding
30th Jun 20211:59 pmPRNNet Asset Value(s)
24th Jun 20214:36 pmPRNDirector/PDMR Shareholding
24th Jun 202112:39 pmPRNDirector/PDMR Shareholding
23rd Jun 20211:59 pmPRNDirector/PDMR Shareholding
23rd Jun 202112:53 pmPRNNet Asset Value(s)
16th Jun 20212:25 pmPRNNet Asset Value(s)
15th Jun 202111:40 amPRNDirector/PDMR Shareholding
9th Jun 20211:57 pmPRNNet Asset Value(s)
2nd Jun 20212:12 pmPRNNet Asset Value(s)
1st Jun 20217:00 amPRNBlocklisting - Interim Review
26th May 20213:47 pmPRNDirector/PDMR Shareholding
26th May 20211:35 pmPRNNet Asset Value(s)
19th May 20213:19 pmPRNNet Asset Value(s)
13th May 202110:41 amPRNDirector/PDMR Shareholding
12th May 20213:53 pmPRNNet Asset Value(s)
6th May 202112:29 pmPRNDirector/PDMR Shareholding
6th May 202111:25 amPRNDirector/PDMR Shareholding
5th May 20212:14 pmPRNNet Asset Value(s)
28th Apr 20212:43 pmPRNNet Asset Value(s)
26th Apr 20212:44 pmPRNDirector/PDMR Shareholding
21st Apr 20212:47 pmPRNNet Asset Value(s)
14th Apr 20213:07 pmPRNNet Asset Value(s)
12th Apr 20213:38 pmPRNDirector/PDMR Shareholding
7th Apr 20213:16 pmPRNNet Asset Value(s)
6th Apr 20214:23 pmPRNDirector/PDMR Shareholding
6th Apr 20212:11 pmPRNDirector/PDMR Shareholding
31st Mar 20212:38 pmPRNNet Asset Value(s)
26th Mar 20214:25 pmPRNDirector/PDMR Shareholding
25th Mar 20214:26 pmPRNDirector/PDMR Shareholding
25th Mar 20214:12 pmPRNDirector/PDMR Shareholding
25th Mar 20212:11 pmPRNDirector/PDMR Shareholding
24th Mar 202112:58 pmPRNNet Asset Value(s)
19th Mar 20212:08 pmPRNDirector/PDMR Shareholding
17th Mar 20211:47 pmPRNNet Asset Value(s)
17th Mar 20217:00 amPRNHalf-year Report
10th Mar 20214:13 pmPRNNet Asset Value(s)
3rd Mar 20211:43 pmPRNNet Asset Value(s)
24th Feb 20211:48 pmPRNNet Asset Value(s)
17th Feb 20213:00 pmPRNNet Asset Value(s)
12th Feb 202112:17 pmPRNDirector/PDMR Shareholding
10th Feb 20213:18 pmPRNNet Asset Value(s)
3rd Feb 20214:18 pmPRNNet Asset Value(s)
1st Feb 202112:25 pmPRNTotal Voting Rights
28th Jan 20214:22 pmPRNDirector/PDMR Shareholding
27th Jan 20213:24 pmPRNNet Asset Value(s)
20th Jan 20213:35 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.